Genomics of lethal prostate cancer at diagnosis and castration resistance

The genomics of primary prostate cancer differ from those of metastatic castration-resistant prostate cancer (mCRPC). We studied genomic aberrations in primary prostate cancer biopsies from patients who developed mCRPC, also studying matching, same-patient, diagnostic, and mCRPC biopsies following t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Invest
Asıl Yazarlar: Mateo, Joaquin, Seed, George, Bertan, Claudia, Rescigno, Pasquale, Dolling, David, Figueiredo, Ines, Miranda, Susana, Nava Rodrigues, Daniel, Gurel, Bora, Clarke, Matthew, Atkin, Mark, Chandler, Rob, Messina, Carlo, Sumanasuriya, Semini, Bianchini, Diletta, Barrero, Maialen, Petermolo, Antonella, Zafeiriou, Zafeiris, Fontes, Mariane, Perez-Lopez, Raquel, Tunariu, Nina, Fulton, Ben, Jones, Robert, McGovern, Ursula, Ralph, Christy, Varughese, Mohini, Parikh, Omi, Jain, Suneil, Elliott, Tony, Sandhu, Shahneen, Porta, Nuria, Hall, Emma, Yuan, Wei, Carreira, Suzanne, de Bono, Johann S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7108902/
https://ncbi.nlm.nih.gov/pubmed/31874108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI132031
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller